These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15755652)

  • 1. Benzotropolone inhibitors of estradiol methylation: kinetics and in silico modeling studies.
    Lambert JD; Chen D; Wang CY; Ai N; Sang S; Ho CT; Welsh WJ; Yang CS
    Bioorg Med Chem; 2005 Apr; 13(7):2501-7. PubMed ID: 15755652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
    Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
    Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase.
    Nagai M; Conney AH; Zhu BT
    Drug Metab Dispos; 2004 May; 32(5):497-504. PubMed ID: 15100171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: a possible mechanism for carcinogenicity.
    Garner CE; Matthews HB; Burka LT
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):124-31. PubMed ID: 10637136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisubstrate inhibitors of the enzyme catechol O-methyltransferase (COMT): efficient inhibition despite the lack of a nitro group.
    Paulini R; Lerner C; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F
    Chembiochem; 2004 Sep; 5(9):1270-4. PubMed ID: 15368579
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
    Bai HW; Shim JY; Yu J; Zhu BT
    Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
    Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
    Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies.
    Chen D; Wang CY; Lambert JD; Ai N; Welsh WJ; Yang CS
    Biochem Pharmacol; 2005 May; 69(10):1523-31. PubMed ID: 15857617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
    Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
    Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 108M polymorph of human catechol O-methyltransferase is prone to deformation at physiological temperatures.
    Rutherford K; Bennion BJ; Parson WW; Daggett V
    Biochemistry; 2006 Feb; 45(7):2178-88. PubMed ID: 16475806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of COMT and ErmC inhibitors by using a microplate assay in combination with library focusing by virtual screening.
    Kreander K; Kurkela M; Siiskonen A; Vuorela P; Tammela P
    Pharmazie; 2006 Mar; 61(3):247-8. PubMed ID: 16599271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisubstrate inhibitors of catechol O-methyltransferase (COMT): the crucial role of the ribose structural unit for inhibitor binding affinity.
    Paulini R; Trindler C; Lerner C; Brändli L; Schweizer WB; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F
    ChemMedChem; 2006 Mar; 1(3):340-57. PubMed ID: 16892369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome.
    Salih SM; Jamaluddin M; Salama SA; Fadl AA; Nagamani M; Al-Hendy A
    Fertil Steril; 2008 May; 89(5 Suppl):1414-21. PubMed ID: 17612537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (-)-epigallocatechin-3-O-gallate.
    Zhu BT; Shim JY; Nagai M; Bai HW
    Xenobiotica; 2008 Feb; 38(2):130-46. PubMed ID: 18197555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee.
    Zhu BT; Wang P; Nagai M; Wen Y; Bai HW
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):65-74. PubMed ID: 19095062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice.
    Zacharia LC; Gogos JA; Karayiorgou M; Jackson EK; Gillespie DG; Barchiesi F; Dubey RK
    Circulation; 2003 Dec; 108(24):2974-8. PubMed ID: 14662705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore modeling and virtual screening studies to design potential COMT inhibitors as new leads.
    Jatana N; Sharma A; Latha N
    J Mol Graph Model; 2013 Feb; 39():145-64. PubMed ID: 23280413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro evaluation of two progressive series of bifunctional polyhydroxybenzamide catechol-O-methyltransferase inhibitors.
    Brevitt SE; Tan EW
    J Med Chem; 1997 Jun; 40(13):2035-9. PubMed ID: 9207944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of rat catechol-O-methyltransferase complexed with coumarine-based inhibitor.
    Tsuji E; Okazaki K; Takeda K
    Biochem Biophys Res Commun; 2009 Jan; 378(3):494-7. PubMed ID: 19056347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.